Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression

BACKGROUND: Cisplatin (CDDP) treatment is one of the most predominant chemotherapeutic strategies for patients with gastric cancer (GC). A better understanding of the mechanisms of CDDP resistance can greatly improve therapeutic efficacy in patients with GC. Circular RNAs (circRNAs) are a class of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoxu, Li, Zheng, Zhang, Qiang, Wang, Weizhi, Li, Bowen, Wang, Lu, Xu, Zhipeng, Zeng, Ailiang, Zhang, Xing, Zhang, Xuan, He, Zhongyuan, Li, Qiang, Sun, Guangli, Wang, Sen, Li, Qing, Wang, Linjun, Zhang, Lu, Xu, Hao, Xu, Zekuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441201/
https://www.ncbi.nlm.nih.gov/pubmed/30927924
http://dx.doi.org/10.1186/s12943-019-0969-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441201/
https://www.ncbi.nlm.nih.gov/pubmed/30927924
http://dx.doi.org/10.1186/s12943-019-0969-3

Ejemplares similares